Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation

International Journal of Artificial Organs

Volumn 31, Issue 6, 2008, Pages 535-544

  Pawlaczyk, K ^a,b   Polubinska, A ^a   Numata, M ^b,c   Nakayama, M ^c   Pecoits Filho, R ^b   Czekalski, S ^a   Lindholm, Bengt ^b   Breborowicz, A ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Cytokines; Lipopolysaccharide; Peritoneal dialysis; Peritoneal inflammation; Peritoneal transport; Vascular endothelial growth factor

Indexed keywords

DIALYSIS; ENDOTHELIAL CELLS; HEMODYNAMICS; RATS; SOLUTE TRANSPORT;

ANIMAL MODEL; CELL COUNT; CYTOKINES; DIALYSATES; LIPOPOLYSACCHARIDES; PERITONEAL DIALYSIS; PERITONEAL INFLAMMATION; PERITONEAL TRANSPORT; SOLUTE TRANSPORT RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

PATHOLOGY;

DIANEAL; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIALYSATE LEVEL; FLUID TRANSPORT; MACROPHAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONITIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; ULTRAFILTRATION;

EID: 49649118573     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803100609     Document Type: Article

References (43)

1. Holmes CJ. Peritoneal host defence mechanisms in peritoneal dialysis. Kidney Int Suppl 1994; 46: S58-70.
2. Zemel D, Krediet RT. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Blood Purif 1996; 14: 198-216.
3. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35: 644-52.
4. Wang T, Cheng HH, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution. Kidney Int 2000; 57: 1704-12.
5. Breborowicz A, Polubinska A, Moberly J, Ogle K, Martis L, Oreopoulos DG. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001; 37: 594-600.
6. Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Polubinska A, Wisniewska J, Faict D, Holmes CJ, Breborowicz A. Bicarbonate/Lactate dialysis solution improves in vivo function of peritoneal host defense in rats. Perit Dial Int 1999; 19: S30-36.
7. Gronow S, Brade H. Lipopolysaccharide biosynthesis: which steps do bacteria need to survive? J Endotoxin Res 2001; 7: 3-23.
8. Gomez-Flores R, Suo JL, Weber RJ. Suppression of splenic macrophage functions following acute morphine actionin the rat mesencephalon peniaqueductal gray. Brain Behav Immun 1999; 13: 212-24.
9. Sironi M, Guglielmotti A, Polentarutti N, Fioretti F, Milanese C, Romano M, Vigini C, Coletta I, Sozzani S, Bernasconi S, Vecchi A, Pinza M, Mantovani A. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Oytokine Netw 1999; 10: 437-42.
10. Zweers MM, Struijk DG, Smit W, Krediet RT. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J Lab Clin Med 2001; 137: 125-32.
11. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 2003; 23: 116-22.
12. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 1999; 10: 2185-96.
13. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13: 721-8.
14. Margetts PJ, Kolb M, Yu L, Hoff CM, Gauldie J. A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit Dial Int 2001; 21 (Suppl 3): S368-72.
15. Pawlaczyk K, Kuzlan-Pawlaczyk M, Wisniewska-Elnur J, Czekalski S, Lindholm B, Breborowicz A. Dose- and time-dependent increase of inflammatory mediators and vascular endothelial growth factor (VEGF) in response to lipopolysaccharide induced acute peritonitis in rats. (Abstract). Nephrol Dial Transplant 2003; 18 (Suppl 4): S219.
16. Lowry OH, Rosebrough NJ, Rarr AL, Randall RJ. Protein mesurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
17. Van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschraegen G, Vijt D, Lameire N. The need for a center-tailored treatment protocol for peritonitis. Perit Dial Int 1998; 18: 274-81.
18. Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis 1994; 23: 569-73.
19. Schafer K, Schumann RR, Stoteknuel S, Schollmeyer P, Dobos GJ. Lipopolysaccharide-binding protein is present in effluents of patients with Gram-negative and Gram-positive CAPD peritonitis. Nephrol Dial Transplant 1998; 13: 969-74.
20. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int 1996; 50 (Suppl): S17-21.
21. Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, Topley N. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54: 2170-83.
22. Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999; 162: 1685-91.
23. Montravers P, Maulin L, Mohler J, Carbon C. Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats. Infect Immun 1999; 67: 1579-84.
24. Sakashita Y, Hiyama E, Imamura Y, Murakami Y, Sugahara Y, Takesue Y, Matsuura Y, Yokoyama T. Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis. Hiroshima J Med Sci 2000; 49: 43-8.
25. Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D, Duverger N, Branellec D, Tedgui A, Levy BI. Antiangiogenic effect of interleukin- 10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000; 87: 448-52.
26. Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson JL, Axelson H, Castanos-Velez E, Ljunggren HG, Malefyt RD, Granger HJ, Ziche M, Bejarano MT. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 2000; 96: 2568-73.
27. Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin10: the melanoma experience. J Interferon Cytokine Res 1999; 19: 697-703.
28. Stearns ME, Garcia FU, Fudge K, Rhim J, Wang M. Role of interleukin 10 and transforming growth factor β1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 1999; 5: 711-20.
29. Bauermeister K, Burger M, Almanasreh N, Knopf HP, Schumann RR, Schollmeyer P, Dobos GJ. Distinct regulation of IL-8 and MCP-1 by LPS and interferon-gamma-treated human peritoneal macrophages. Nephrol Dial Transplant 1998; 13: 1412-9.
30. Tekstra J, Visser CE, Tuk CW, Brouwer-Steenbergen JJ, Burger CW, Krediet RT, Beelen RH. Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2379-84.
31. Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, Verity A, Perretti M. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 1998; 63: 108-16.
32. Riese J, Denzel C, Zowe M, Mehler C, Hohenberger W, Haupt W. Production of chemokines by the human peritoneum. Zentralbl Chir 1999; 124: 206-9.
33. Flessner MF. Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit Dial Int 1999; 19: S77-82.
34. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997; 18: 4-25.
35. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
36. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
37. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-7.
38. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48: 1131-7.
39. Ha H, Cha MK, Choi HN, Lee HB. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 2002; 22: 171-7.
40. Seo KH, Ko HM, Choi JH, Jung HH, Chun YH, Choi IW, Lee HK, Im SY. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis. Eur J Immunol 2004; 34: 2129-37.
41. Webb NJ, Myers CR, Watson CJ, Bottomley, MJ, Brenchley PE. Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 1998; 10: 254-7.
42. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101: 40-50.
43. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998; 4: 336-40.